Understanding the Importance of IOP Variables in Glaucoma: A Systematic Review

Survey of Ophthalmology

Volumn 54, Issue 6, 2009, Pages 643-662

  Sultan, Marla B ^a,b   Mansberger, Steven L ^c   Lee, Paul P ^d  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b PFIZER INC   (United States)

^c DEVERS EYE INSTITUTE   (United States)

^d DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

adrenergic beta antagonists; carbonic anhydrase inhibitors; glaucoma; intraocular pressure; ocular tonometry; ophthalmologic diagnostic techniques; prostaglandin analogs

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST; WATER;

AMBULATORY CARE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CORNEA THICKNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DRUG EFFICACY; EVENING DOSAGE; GLAUCOMA; HOME CARE; HUMAN; HYSTERESIS; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LITERATURE; LONG TERM CARE; MONOTHERAPY; MORNING DOSAGE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT POSITIONING; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RISK REDUCTION; SELF CARE; SLEEP WAKING CYCLE; STANDARDIZATION; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TEST RETEST RELIABILITY; TONOMETRY; TRABECULOPLASTY; TREATMENT DURATION; TREATMENT INDICATION; VALIDATION PROCESS;

ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; TONOMETRY, OCULAR;

EID: 70349758498     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.05.001     Document Type: Review

References (130)

1. Agarwal H.C., Sihota R., Das C., and Dada T. Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol 86 7 (2002) 733-736
2. AGIS (Advanced Glaucoma Intervention Study) Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 4 (2000) 429-440
3. Alm A., and Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology 102 12 (1995) 1743-1752
4. Alm A., and Widengard I. Latanoprost: experience of 2-year treatment in Scandinavia. Acta Ophthalmol Scand 78 1 (2000) 71-76
5. American Academy of Ophthalmology. Basic and Clinical Science Course (2006), American Academy of Ophthalmology, San Francisco, CA
6. American Academy of Ophthalmology Preferred Practice Patterns Committee Glaucoma Panel. Preferred Practice Pattern. Primary Open-Angle Glaucoma (2003), American Academy of Ophthalmology, San Francisco, CA
7. Anderson D.R., and Grant W.M. The influence of position on intraocular pressure. Invest Ophthalmol Vis Sci 12 3 (1973) 204-212
8. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9 2 (2000) 134-142
9. Barkana Y., Anis S., Liebmann J., et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 124 6 (2006) 793-797
10. Bengtsson B., and Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol 243 6 (2005) 513-518
11. Bergea B., Bodin L., and Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 106 5 (1999) 997-1004
12. Bhan A., Bhargava J., Vernon S.A., et al. Repeatability of ocular blood flow pneumotonometry. Ophthalmology 110 8 (2003) 1551-1554
13. Bhan A., Browning A.C., Shah S., et al. Effect of corneal thickness on intraocular pressure measurements with the pneumotonometer, Goldmann applanation tonometer, and Tono-Pen. Invest Ophthalmol Vis Sci 43 5 (2002) 1389-1392
14. Boothe W.A., Lee D.A., Panek W.C., et al. The Tono-Pen. A manometric and clinical study. Arch Ophthalmol 106 9 (1988) 1214-1217
15. Brandt J.D., Beiser J.A., Gordon M.O., et al. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol 138 5 (2004) 717-722
16. Browning A.C., Bhan A., Rotchford A.P., et al. The effect of corneal thickness on intraocular pressure measurement in patients with corneal pathology. Br J Ophthalmol 88 11 (2004) 1395-1399
17. Burgoyne C.F., Downs J.C., Bellezza A.J., et al. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 24 1 (2005) 39-73
18. Camras C.B., Alm A., Watson P., et al. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology 103 11 (1996) 1916-1924
19. Collaborative Initial Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126 (1998) 487-497
20. Collaborative Initial Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
21. Congdon N., O'Colmain B., Klaver C.C., et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 4 (2004) 477-485
22. Congdon N.G., Broman A.T., Bandeen-Roche K., et al. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol 141 5 (2006) 868-875
23. Copt R.P., Thomas R., and Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol 117 1 (1999) 14-16
24. Daugeliene L., Yamamoto T., and Kitazawa Y. Effect of trabeculectomy on visual field in progressive normal-tension glaucoma. Jpn J Ophthalmol 42 4 (1998) 286-292
25. Diestelhorst M., and Krieglstein G.K. The effect of the water-drinking test on aqueous humor dynamics in healthy volunteers. Graefes Arch Clin Exp Ophthalmol 232 3 (1994) 145-147
26. Doughty M.J., and Zaman M.L. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 44 5 (2000) 367-408
27. Drance S.M. Diurnal variation of intraocular pressure in treated glaucoma. Significance in patients with chronic simple glaucoma. Arch Ophthalmol 70 (1963) 302-311
28. Ehlers N., Bramsen T., and Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol Scand 53 1 (1975) 34-43
29. Eisenberg D.L., Sherman B.G., McKeown C.A., et al. Tonometry in adults and children. A manometric evaluation of pneumotonometry, applanation, and Tono-Pen in vitro and in vivo. Ophthalmology 105 7 (1998) 1173-1181
30. Esgin H., Alimgil M.L., and Erda S. Clinical comparison of the ocular blood flow tonograph and the Goldmann applanation tonometer. Eur J Ophthalmol 8 3 (1998) 162-166
31. Frankelson E.N. The role of the water test in evaluation of glaucoma control. Can J Ophthalmol 9 4 (1974) 408-410
32. Friedman D.S., Wolfs R.C., O'Colmain B.J., et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 122 4 (2004) 532-538
33. Gandolfi S., Simmons S.T., Sturm R., et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther 18 3 (2001) 110-121
34. Goldberg I., Cunha-Vaz J., Jakobsen J.E., et al. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J Glaucoma 10 5 (2001) 414-422
35. Gonzalez I., Pablo L.E., Pueyo M., et al. Assessment of diurnal tensional curve in early glaucoma damage. Int Ophthalmol 20 1-3 (1997) 113-115
36. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 6 (2002) 714-720 discussion 829-30
37. Grant W.M., and Burke Jr. J.F. Why do some people go blind from glaucoma?. Ophthalmology 89 9 (1982) 991-998
38. Greenidge K.C., Spaeth G.L., and Fiol-Silva Z. Effect of argon laser trabeculoplasty on the glaucomatous diurnal curve. Ophthalmology 90 7 (1983) 800-804
39. Gunvant P., Baskaran M., Vijaya L., et al. Effect of corneal parameters on measurements using the pulsatile ocular blood flow tonograph and Goldmann applanation tonometer. Br J Ophthalmol 88 4 (2004) 518-522
40. Hattenhauer M.G., Johnson D.H., Ing H.H., et al. The probability of blindness from open-angle glaucoma. Ophthalmology 105 11 (1998) 2099-2104
41. Heijl A., and Bengtsson B. The short-term effect of laser trabeculoplasty on the glaucomatous visual field. A prospective study using computerized perimetry. Acta Ophthalmol Scand 62 6 (1984) 705-714
42. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 10 (2002) 1268-1279
43. Herndon L.W., Weizer J.S., and Stinnett S.S. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 122 1 (2004) 17-21
44. Higginbotham E.J., Feldman R., Stiles M., et al. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. Arch Ophthalmol 120 7 (2002) 915-922
45. Horowitz G.S., Byles J., Lee J., et al. Comparison of the Tono-Pen and Goldmann tonometer for measuring intraocular pressure in patients with glaucoma. Clin Exp Ophthalmol 32 6 (2004) 584-589
46. Hughes E., Spry P., and Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma 12 3 (2003) 232-236
47. Jonas J.B., Budde W.M., Stroux A., et al. Diurnal intraocular pressure profiles and progression of chronic open-angle glaucoma. Eye 21 7 (2007) 948-951
48. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 6 (2002) 701-713 discussion 829-30
49. Kaufmann C., Bachmann L.M., Robert Y.C., et al. Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry. Arch Ophthalmol 124 8 (2006) 1104-1108
50. Kaufmann C., Bachmann L.M., and Thiel M.A. Comparison of dynamic contour tonometry with Goldmann applanation tonometry. Invest Ophthalmol Vis Sci 45 9 (2004) 3118-3121
51. Kim J.W., and Chen P.P. Central corneal pachymetry and visual field progression in patients with open-angle glaucoma. Ophthalmology 111 11 (2004) 2126-2132
52. Kniestedt C., Lin S., Choe J., et al. Clinical comparison of contour and applanation tonometry and their relationship to pachymetry. Arch Ophthalmol 123 11 (2005) 1532-1537
53. Kniestedt C., Nee M., and Stamper R.L. Accuracy of dynamic contour tonometry compared with applanation tonometry in human cadaver eyes of different hydration states. Graefes Arch Clin Exp Ophthalmol 243 4 (2005) 359-366
54. Ko Y.C., Liu C.J.I., and Hsu W.M. Varying effects of corneal thickness on intraocular pressure measurements with different tonometers. Eye 19 3 (2005) 327-332
55. Kohlhaas M., Boehm A.G., Spoerl E., et al. Effect of central corneal thickness, corneal curvature, and axial length on applanation tonometry. Arch Ophthalmol 124 4 (2006) 471-476
56. Konstas A.G., Boboridis K., Tzetzi D., et al. Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy. Arch Ophthalmol 123 7 (2005) 898-902
57. Konstas A.G., Kozobolis V.P., Tersis I., et al. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye 17 1 (2003) 41-46
58. Konstas A.G., Maltezos A., Bufidis T., et al. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye 14 1 (2000) 73-77
59. Konstas A.G., Maltezos A.C., Gandi S., et al. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma. Am J Ophthalmol 128 1 (1999) 15-20
60. Konstas A.G., Mylopoulos N., Karabatsas C.H., et al. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye 18 9 (2004) 893-899
61. Konstas A.G., Topouzis F., Leliopoulou O., et al. 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 113 5 (2006) 761-765
62. Kotecha A., White E.T., Shewry J.M., et al. The relative effects of corneal thickness and age on Goldmann applanation tonometry and dynamic contour tonometry. Br J Ophthalmol 89 12 (2005) 1572-1575
63. Kothy P., Vargha P., and Hollo G. Ocuton-S self tonometry vs. Goldmann tonometry; a diurnal comparison study. Acta Ophthalmol Scand 79 3 (2001) 294-297
64. Laibovitz R.A., Van Denburgh A.M., Felix C., et al. Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management. Arch Ophthalmol 119 7 (2001) 994-1000
65. Laiquzzaman M., Bhojwani R., Cunliffe I., et al. Diurnal variation of ocular hysteresis in normal subjects: relevance in clinical context. Clin Exp Ophthalmol 34 2 (2006) 114-118
66. Leske M.C., Heijl A., Hussein M., et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 1 (2003) 48-56
67. Lichter P.R., Musch D.C., Gillespie B.W., et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 11 (2001) 1943-1953
68. Lim J.I., Blair N.P., Higginbotham M.D., et al. Assessment of intraocular pressure in vitrectomized gas-containing eyes. A clinical and manometric comparison of the Tono-Pen to the pneumotonometer. Arch Ophthalmol 108 5 (1990) 684-688
69. Liu J.H., Bouligny R.P., Kripke D.F., et al. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci 44 10 (2003) 4439-4442
70. Liu J.H., Kripke D.F., Hoffman R.E., et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci 39 13 (1998) 2707-2712
71. Liu J.H., Kripke D.F., Twa M.D., et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci 40 12 (1999) 2912-2917
72. Liu J.H., Kripke D.F., and Weinreb R.N. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J Ophthalmol 138 3 (2004) 389-395
73. Liu J.H., Zhang X., Kripke D.F., et al. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 44 4 (2003) 1586-1590
74. Mao L.K., Stewart W.C., and Shields M.B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 111 1 (1991) 51-55
75. Martinez-Bello C., Chauhan B.C., Nicolela M.T., et al. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol 129 3 (2000) 302-308
76. Martinez-de-la-Casa J.M., Garcia-Feijoo J., Fernandez-Vidal A., et al. Ocular response analyzer versus Goldmann applanation tonometry for intraocular pressure measurements. Invest Ophthalmol Vis Sci 47 10 (2006) 4410-4414
77. Mastropasqua L., Carpineto P., Ciancaglini M., et al. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Ophthalmology 106 3 (1999) 550-555
78. Medeiros F.A., Pinheiro A., Moura F.C., et al. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 18 6 (2002) 489-498
79. Medeiros F.A., Sample P.A., and Weinreb R.N. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes. Ophthalmology 110 10 (2003) 1903-1908
80. Medeiros F.A., Sample P.A., Zangwill L.M., et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 136 5 (2003) 805-813
81. Medeiros F.A., and Weinreb R.N. Evaluation of the influence of corneal biomechanical properties on intraocular pressure measurements using the ocular response analyzer. J Glaucoma 15 5 (2006) 364-370
82. Michaud J.E., and Friren B. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol 132 2 (2001) 235-243
83. Miller D. The relationship between diurnal tension variation and the water-drinking test. Am J Ophthalmol 58 (1964) 243-246
84. Mosaed S., Liu J.H., and Weinreb R.N. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol 139 2 (2005) 320-324
85. Mundorf T., Williams R., Whitcup S., et al. A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension. J Ocul Pharmacol Ther 19 1 (2003) 37-44
86. Nduaguba C., and Lee R.K. Glaucoma screening: current trends, economic issues, technology, and challenges. Curr Opin Ophthalmol 17 2 (2006) 142-152
87. Netland P.A., Landry T., Sullivan E.K., et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 132 4 (2001) 472-484
88. Noël C., Kabo A.M., Romanet J.P., et al. Twenty-four-hour time course of intraocular pressure in healthy and glaucomatous Africans: relation to sleep patterns. Ophthalmology 108 1 (2001) 139-144
89. Nordmann J.P., Mertz B., Yannoulis N.C., et al. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. Am J Ophthalmol 133 1 (2002) 1-10
90. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 9 (2004) 1627-1635
91. O'Brien C., Schwartz B., Takamoto T., et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 111 4 (1991) 491-500
92. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol Scand 65 (1987) 27-29
93. Oliveira C., Tello C., Liebmann J., et al. Central corneal thickness is not related to anterior scleral thickness or axial length. J Glaucoma 15 3 (2006) 190-194
94. Oliver J.E., Hattenhauer M.G., Herman D., et al. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 133 6 (2002) 764-772
95. Orssengo G.J., and Pye D.C. Determination of the true intraocular pressure and modulus of elasticity of the human cornea in vivo. Bull Math Biol 61 3 (1999) 551-572
96. Orzalesi N., Rossetti L., Bottoli A., et al. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 113 2 (2006) 239-246
97. Orzalesi N., Rossetti L., Bottoli A., et al. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol 121 4 (2003) 453-457
98. Orzalesi N., Rossetti L., Invernizzi T., et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 41 9 (2000) 2566-2573
99. Parrish R.K., Palmberg P., and Sheu W.P. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 135 5 (2003) 688-703
100. Pfeiffer N. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol 240 (2002) 893-899
101. Pizzarello L., Abiose A., Ffytche T., et al. VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol 122 4 (2004) 615-620
102. Roth J.A. Inadequate diagnostic value of the water-drinking test. Br J Ophthalmol 58 1 (1974) 55-61
103. Sánchez-Tocino R., Bringas-Calvo R., and Igleseas-Cortiñas D. Comparative study between the non-contact pneumotonometer Can TX10 and the Goldmann tonometer. Arch Soc Esp Oftalmol 80 11 (2005) 643-649
104. Schuman J.S., Horwitz B., Choplin N.T., et al. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Arch Ophthalmol 115 7 (1997) 847-852
105. Shaarawy T., Flammer J., and Haefliger I.O. Reducing intraocular pressure: is surgery better than drugs?. Eye 18 12 (2004) 1215-1224
106. Shedden A., Laurence J., and Tipping R. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study. Clin Ther 23 3 (2001) 440-450
107. Sherwood M., and Brandt J. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 45 Suppl 4 (2001) S361-S368
108. Shoji N., Ogata H., Suyama H., et al. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study. Curr Med Res Opin 21 4 (2005) 503-508
109. Sigal I.A., Flanagan J.G., and Ethier C.R. Factors influencing optic nerve head biomechanics. Invest Ophthalmol Vis Sci 46 11 (2005) 4189-4199
110. Singh R.P., Goldberg I., Graham S.L., et al. Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension. J Glaucoma 10 3 (2001) 206-210
111. Sit A.J., Weinreb R.N., Crowston J.G., et al. Sustained effect of travoprost on diurnal and nocturnal intraocular pressure. Am J Ophthalmol 141 6 (2006) 1131-1133
112. Spraul C.W., Lang G.E., Ronzani M., et al. Reproducibility of measurements with a new slit lamp-mounted ocular blood flow tonograph. Graefes Arch Clin Exp Ophthalmol 236 4 (1998) 274-279
113. Stewart W.C., Stewart J.A., Day D., et al. Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily. Acta Ophthalmol Scand 81 3 (2003) 242-246
114. Susanna Jr. R., Vessani R.M., Sakata L., et al. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol 89 10 (2005) 1298-1301
115. Theofylaktopoulos I., Diestelhorst M., and Krieglstein G.K. Self-tonometry with the Ocuton S versus Goldmann tonometry. Graefes Arch Clin Exp Ophthalmol 237 (1999) 720-724
116. Thomas R., Parikh R., George R., et al. Five-year risk of progression of ocular hypertension to primary open angle glaucoma. A population-based study. Indian J Ophthalmol 51 4 (2003) 329-333
117. Tomita G., Araie M., Kitazawa Y., et al. A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye 18 10 (2004) 984-989
118. Tonnu P.A., Ho T., Newson T., et al. The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry. Br J Ophthalmol 89 7 (2005) 851-854
119. Tonnu P.A., Ho T., Sharma K., et al. A comparison of four methods of tonometry: method agreement and interobserver variability. Br J Ophthalmol 89 7 (2005) 847-850
120. Walker R.E., and Litovitz T.L. An experimental and theoretical study of the pneumatic tonometer. Exp Eye Res 13 1 (1972) 14-23
121. Watson P.G. Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group. Ophthalmology 105 1 (1998) 82-87
122. Wax M.B., Camras C.B., Fiscella R.G., et al. Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol 133 Suppl (2002) S1-S10
123. Wilensky J.T., Gieser D.K., Mori M.T., et al. Self-tonometry to manage patients with glaucoma and apparently controlled intraocular pressure. Arch Ophthalmol 105 8 (1987) 1072-1075
124. Wilensky J.T., Zeimer R.C., Gieser D.K., et al. The effects of glaucoma filtering surgery on the variability of diurnal intraocular pressure. Trans Am Ophthalmol Soc 92 (1994) 377-381 discussion 81-3
125. Wilson M.W., Quinn G.E., Ling G.S., et al. The relation of axial length and intraocular pressure fluctuations in human eyes. Invest Ophthalmol Vis Sci 47 5 (2006) 1778-1784
126. Yang Y.C., Illango B., and Cook M. Intraocular pressure and pulse rate measurements by the OBF tonograph-comparison to reference instruments. Ophthalmic Physiol Opt 20 5 (2000) 401-407
127. Zeimer R.C., Wilensky J.T., Gieser D.K., et al. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology 98 1 (1991) 64-69
128. Zeimer R.C., Wilensky J.T., Gieser D.K., et al. Application of a self-tonometer to home tonometry. Arch Ophthalmol 104 1 (1986) 49-53
129. Zeimer R.C., Wilensky J.T., Gieser D.K., et al. Evaluation of a self tonometer for home use. Arch Ophthalmol 101 11 (1983) 1791-1793
130. Zeppieri M., Brusini P., and Miglior S. Corneal thickness and functional damage in patients with ocular hypertension. Eur J Ophthalmol 15 2 (2005) 196-201